Editor's ChoiceFOCIS HIGHLIGHTS

Two mAbs take a stab at influenza's NActive site

See allHide authors and affiliations

Science Immunology  06 Nov 2020:
Vol. 5, Issue 53, eabf4907
DOI: 10.1126/sciimmunol.abf4907

Abstract

Two human-derived recombinant mAbs specific for IBV bind the neuraminidase active site by emulating the enzymatic substrate, which results in broad protection.

View Full Text

Stay Connected to Science Immunology